Stay updated on BTD-001 in IH & Narcolepsy Type 2 Clinical Trial

Sign up to get notified when there's something new on the BTD-001 in IH & Narcolepsy Type 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BTD-001 in IH & Narcolepsy Type 2 Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study completion date for a clinical trial related to the safety and efficacy of BTD-001 in patients with Idiopathic Hypersomnia or Narcolepsy Type 2.
    Difference
    0.1%
    Check dated 2024-06-06T14:34:09.000Z thumbnail image
  6. Check
    20 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying that researchers are looking for individuals who meet ICSD-3 criteria for IH or Narcolepsy Type 2 and are not undergoing pharmacologic treatment. The criteria also include requirements such as a minimum of 6 hours of nightly sleep, an Epworth Sleepiness Scale score of 10 or greater, and specific age and health conditions.
    Difference
    16%
    Check dated 2024-05-22T21:28:13.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T23:00:34.000Z thumbnail image

Stay in the know with updates to BTD-001 in IH & Narcolepsy Type 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BTD-001 in IH & Narcolepsy Type 2 Clinical Trial page.